Evidence map›Paper›PMID 24048267›Full record

ReviewThrombosis and haemostasis2013

Protein degradation systems in platelets.

B F Kraemer, A S Weyrich, S Lindemann

Abstract readReview
In one paragraph

Review in Thrombosis and haemostasis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Proteome and functional decline as platelets age in the circulation.Journal of thrombosis and haemostasis : JTH · 2021
    Article
  2. The Role of the Proteasome in Platelet Function.International journal of molecular sciences · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis.Arteriosclerosis, thrombosis, and vascular biology · 2015
    Article
  8. Article
  9. Proteasome function is required for platelet production.The Journal of clinical investigation · 2014
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

B F KraemerAndrew Weyrich, MD, Eccles Institute of Human Genetics, Department of Internal Medicine, University of Utah, Salt Lake City, Building 533 Room 4220, Salt Lake City, Utah 84112, USA, Tel: +1 801 5850702, Fax: +1 801 5850701, E-mail: andy.weyrich@u2m2.utah.edu.
A S Weyrich
S Lindemann

Funding

Translational Research Skills Development CoreU54HL112311 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S, ZIMMERMAN, GUY A. · 2012 to 2016
$12.9M
TRANSLATIONAL EVENTS IN PLATELETSR01HL066277 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2001 to 2012
$3.8M
NHLBI NIH HHS R01 HL066277NHLBI NIH HHS U54 HL112311
6 · The paper itself

Abstract

Protein synthesis and degradation are essential processes that allow cells to survive and adapt to their surrounding milieu. In nucleated cells, the degradation and/or cleavage of proteins is required to eliminate aberrant proteins. Cells also degrade proteins as a mechanism for cell signalling and complex cellular functions. Although the last decade has convincingly shown that platelets synthesise proteins, the roles of protein degradation in these anucleate cytoplasts are less clear. Here we review what is known about protein degradation in platelets placing particular emphasis on the proteasome and the cysteine protease calpain.

Indexed as

AnimalsBlood PlateletsCysteine ProteasesHumansProteasome Endopeptidase ComplexProteolysisSignal TransductionCysteine ProteasesProteasome Endopeptidase ComplexcalpainPlateletsproteasomeprotein degradation

Identifiers

PMID24048267
PMCPMC3971729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.